48,833
edits
Line 9: | Line 9: | ||
*2018 meta-analysis: PD-L1 is a poor prognosticator in RCC (HR~2.76)[https://www.ncbi.nlm.nih.gov/pubmed/29362922] | *2018 meta-analysis: PD-L1 is a poor prognosticator in RCC (HR~2.76)[https://www.ncbi.nlm.nih.gov/pubmed/29362922] | ||
==CPS and TPS== | |||
CPS in lymph nodes: | |||
https://pubmed.ncbi.nlm.nih.gov/35420378/ | |||
https://pmc.ncbi.nlm.nih.gov/articles/PMC7413953/ | |||
https://pmc.ncbi.nlm.nih.gov/articles/PMC10078903/ | |||
https://surgexppathol.biomedcentral.com/articles/10.1186/s42047-019-0033-z | |||
==References== | ==References== | ||
{{Reflist|1}} | {{Reflist|1}} |
edits